APA (7th ed.) Citation

Verhaar, M. C., Strachan, F. E., Newby, D. E., Cruden, N. L., Koomans, H. A., Rabelink, T. J., & Webb, D. J. (1998). Endothelin-A Receptor Antagonist–Mediated Vasodilatation Is Attenuated by Inhibition of Nitric Oxide Synthesis and by Endothelin-B Receptor Blockade. Circulation (New York, N.Y.), 97(8), 752-756. https://doi.org/10.1161/01.CIR.97.8.752

Chicago Style (17th ed.) Citation

Verhaar, Marianne C., Fiona E. Strachan, David E. Newby, Nicholas L. Cruden, Hein A. Koomans, Ton J. Rabelink, and David J. Webb. "Endothelin-A Receptor Antagonist–Mediated Vasodilatation Is Attenuated by Inhibition of Nitric Oxide Synthesis and by Endothelin-B Receptor Blockade." Circulation (New York, N.Y.) 97, no. 8 (1998): 752-756. https://doi.org/10.1161/01.CIR.97.8.752.

MLA (9th ed.) Citation

Verhaar, Marianne C., et al. "Endothelin-A Receptor Antagonist–Mediated Vasodilatation Is Attenuated by Inhibition of Nitric Oxide Synthesis and by Endothelin-B Receptor Blockade." Circulation (New York, N.Y.), vol. 97, no. 8, 1998, pp. 752-756, https://doi.org/10.1161/01.CIR.97.8.752.